MegaPro Biomedical Co Ltd
TPEX:6827
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
|
M
|
MegaPro Biomedical Co Ltd
TPEX:6827
|
TW |
Valor intrínseco
No hay suficientes datos para calcular de forma fiable el valor intrínseco de MegaPro Biomedical Co Ltd.
¿Nuestras valoraciones funcionan de verdad? Ver resultados del backtest .
Análisis fundamental
Qué hace MegaPro Biomedical
MegaPro Biomedical Co., Ltd. engages in the development of drug ingredients related to nanoparticles and nanocell technology platforms. The company is headquartered in Zhubei, Hsinchu and currently employs 26 full-time employees. The company went IPO on 2021-10-19. The firm mainly has two nanotechnology platforms including nanoparticle and nanocell. The firm's products include MPB-1514, MPB-1523, MPB-1734 and MPB-2043.
- Sede central
- Taiwán TW
- Empleados
- 26
- Fecha de salida a bolsa
- 19 oct., 2021